ORBAPIN 5/20 (Amlodipine BP 5 mg & Olmesartan INN 20 mg)
Presented by
Mohammed Moshiur Rahaman
Senior Brand Executive
Brand Management Department
Strategic Brand Management Division
The ACME Laboratories Ltd.
ORBAPIN 5/20(Amlodipine 5 mg & Olmesartan 20 mg)
ORBA from ORBAS & PIN from AMLOPIN
Price & Supply
Price: Orbapin 5/20 mg (08 taka)
Supply: 3x10 tablets
Product Group : A
Available Olmesartan & Combination (1Q, 2014)
Generic Introduce (Year)
Market (Crore)
Growth
Olmesartan
2010 18.5 50
Olmesrtan + HCTZ
2010 10.28 21
Olmesartan+
Amlodipine
2010 29.47 63
Olmesartan & Amlodipine (2Q, 2014)
Generic Company Market (Crore)
Growth
Bizoran Beximco 17.14 42
Abecab ACI 5.05 108
Camlosart Square 3.56 999
Olmezest AM
Sun 2.34 70
Indication
For the treatment of hypertension, alone or with other antihypertensive agents.
Dosage & AdministrationOrbapin 5/20 mg Once daily OR may be increased after 2 weeks to a maximum dose of two tablets
Recommended for patients with moderate to marked renal impairment (Creatinine clearance < 40 mL/min)
Not recommended
In patient's ≥ 75 years old OrWith hepatic impairment OrBelow Creatinine Clearance <20 mL/min
Target doctorsCardiologistEndocrinologistNeurologistMedicine specialistNephrologist